YOQNEAM, Israel & SAN RAMON, Calif.--(BUSINESS WIRE)--UltraShape announced today that it has been granted a medical device license to sell the UltraShape™ CONTOUR I system for non-invasive fat emulsification for the purpose of aesthetic body contouring in accordance with Health Canada’s medical device regulations. UltraShape is the first clinically proven non-invasive solution for body contouring based on focused ultrasound technology. It has been demonstrated to deliver durable and measurable circumference and fat thickness reduction in a single treatment and incremental reduction with multiple treatments.
